Skip to main content
Log in

Impact of Institutional Review Boards on cancer research

  • Published:
The Journal of Bioethics Aims and scope Submit manuscript

Abstract

The concepts of informed consent and surveillance of human research designed to protect human subjects is commendable. The regulations of the Institutional Review Board (IRB) are having a major impact on clinical cancer research. There is greater administrative time needed of the investigator, the mechanisms of patient care have become cumbersome and some patients reject optional medical management that could be life saving. IRB regulations must be flexible to meet the needs of human subjects as well as those of the clinical investigator.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kennedy, B.K., Calabresi, P., Carbone, P.P., Frei, E. III, Holland, J.F., Owens, A.H., Sleisinger, M.H., & Beck, J.C. Training program in medical oncology.Am Intern Med, 78, 1973, 127–130.

    Google Scholar 

  2. Frereich, E.The Cancer Letter, 7, November 6, 1981, 5.

    Google Scholar 

  3. Kennedy, B.J. & Lillehaugen, A. Patient recall of informed consent.Med and Ped Onc, 7, 1979, 173–178.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kennedy, B.J. Impact of Institutional Review Boards on cancer research. J Med Hum 5, 27–32 (1984). https://doi.org/10.1007/BF01103644

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01103644

Keywords

Navigation